Mortality Associated with Tuberculosis/HIV Co-infection Among Patients on TB Treatment in the Limpopo Province, South Africa

Overview

Journal Afr Health Sci

Date 2015 Apr 3

PMID 25834493

Citations 29

Authors

Tiyani E Mabunda

Nalezani J Ramalivhana

Yoswa M Dambisya

Affiliations

Soon will be listed here.

Abstract

Background: South Africa has a high tuberculosis burden, and Limpopo Province experienced higher than national average TB mortality rates between 1997 and 2008.

Objective: To establish factors associated with TB mortality in Limpopo Province in 2008.

Design: Retrospective study using provincial data for patients who died after commencing TB treatment between 01 January 2008 and 31 December 2008.

Results: In 2008, some 18074 patients started treatment: 15995 (88.5%) had pulmonsry TB (PTB), while 2079 (11.5%) had Extra pulmonary TB (EPTB). Overall, 2242 (12.4%) patients died, mainly PTB patients (n=1906; 85%), more males (n=1159, 51.7%), mainly those aged 25 to 54 years (n=1749, 78.0%), and new cases (1914; 85.4%). TB mortality was significantly higher among smear negative than smear positive patients (17% vs 13.8%; P<0.001), among those with EPTB compared to PTB patients (P<0.001), and among re-treatment cases (P<0.001). Only 4237 (23.4%) patients had HIV status known, with higher mortality found among HIV positive than the HIV negative patients (P<0.0001); but HIV status was not known for the majority who died (n=1685, 75.2%).

Conclusion: Higher mortality was associated with age 22-55 years; smear negativity, EPTB, HIV infection, and re-treatment. The findings call for greater integration of TB control efforts and HIV services, especially among the 22-55 year age group.

Citing Articles

Mortality and predictors among HIV-TB co-infected patients in Ethiopia: A systematic review and meta-analysis.

Wondie W, Wubneh C, Legesse B, Mekonen G, Zemariam A, Gebreegziabher Z PLoS One. 2025; 20(1):e0317048.

PMID: 39761319 PMC: 11703055. DOI: 10.1371/journal.pone.0317048.

Predicting Treatment Outcomes in Patients with Drug-Resistant Tuberculosis and Human Immunodeficiency Virus Coinfection, Using Supervised Machine Learning Algorithm.

Hosu M, Faye L, Apalata T Pathogens. 2024; 13(11).

PMID: 39599476 PMC: 11597124. DOI: 10.3390/pathogens13110923.

Burden of mortality and its predictors among TB-HIV co-infected patients in Ethiopia: Systematic review and meta-analysis.

Kassaw A, Kefale D, Aytenew T, Azmeraw M, Agimas M, Zeleke S PLoS One. 2024; 19(11):e0312698.

PMID: 39509354 PMC: 11542784. DOI: 10.1371/journal.pone.0312698.

Mortality and associated factors among patients with TB-HIV co-infection in Ethiopia: a systematic review and meta-analysis.

Moges S, Lajore B BMC Infect Dis. 2024; 24(1):773.

PMID: 39095740 PMC: 11295522. DOI: 10.1186/s12879-024-09683-5.

Factors associated with mortality among laboratory-diagnosed drug-resistant tuberculosis patients on treatment, KwaZulu-Natal Province, 2017-2019.

Phafane M, Ngozo J, Radebe Z, Lutge E, Ebonwu J Pan Afr Med J. 2024; 47:181.

PMID: 39092023 PMC: 11293477. DOI: 10.11604/pamj.2024.47.181.34571.

References

Rao V, Iademarco E, Fraser V, Kollef M . The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest. 1998; 114(5):1244-52. DOI: 10.1378/chest.114.5.1244. View

Abdool Karim S, Churchyard G, Abdool Karim Q, Lawn S . HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet. 2009; 374(9693):921-33. PMC: 2803032. DOI: 10.1016/S0140-6736(09)60916-8. View

Schreiber Y, Herrera A, Wilson D, Wallengren K, Draper R, Muller J . Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area. Int J Tuberc Lung Dis. 2009; 13(10):1274-80. View

Silva D, Menegotto D, Schulz L, Gazzana M, Dalcin P . Factors associated with mortality in hospitalized patients with newly diagnosed tuberculosis. Lung. 2010; 188(1):33-41. DOI: 10.1007/s00408-009-9224-9. View

Komati S, Shaw P, Stubbs N, Mathibedi M, Malan L, Sangweni P . Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa. AIDS. 2010; 24(12):1849-55. PMC: 2904641. DOI: 10.1097/QAD.0b013e32833a2507. View

Hansel N, Wu A, Chang B, Diette G . Quality of life in tuberculosis: patient and provider perspectives. Qual Life Res. 2004; 13(3):639-52. DOI: 10.1023/B:QURE.0000021317.12945.f0. View

Jones-Lopez E, Ayakaka I, Levin J, Reilly N, Mumbowa F, Dryden-Peterson S . Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study. PLoS Med. 2011; 8(3):e1000427. PMC: 3058098. DOI: 10.1371/journal.pmed.1000427. View

Peter J, Theron G, Singh N, Singh A, Dheda K . Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings. Eur Respir J. 2013; 43(1):185-94. PMC: 5454491. DOI: 10.1183/09031936.00198012. View

Whalen C, Nsubuga P, Okwera A, Johnson J, Hom D, Michael N . Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS. 2000; 14(9):1219-28. PMC: 2869086. DOI: 10.1097/00002030-200006160-00020. View

10.

Badri M, Ehrlich R, Wood R, Pulerwitz T, Maartens G . Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. Int J Tuberc Lung Dis. 2001; 5(3):225-32. View

11.

Jeena P, Pillay P, Pillay T, Coovadia H . Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. Int J Tuberc Lung Dis. 2002; 6(8):672-8. View

12.

Straetemans M, Bierrenbach A, Nagelkerke N, Glaziou P, van der Werf M . The effect of tuberculosis on mortality in HIV positive people: a meta-analysis. PLoS One. 2011; 5(12):e15241. PMC: 3012688. DOI: 10.1371/journal.pone.0015241. View